Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment

Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19...

from NDTV News - Special https://ift.tt/3vLxZQ6